Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

481 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjunctive Pascolizumab in Rifampicin-Susceptible Pulmonary Tuberculosis: Proof-of-Concept, Partially-Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Trial.
Paton NI, Gurumurthy M, Lu Q, Leek F, Kwan P, Koh HWL, Molton J, Mortera L, Naval S, Bakar ZA, Pang YK, Lum L, Lim TK, Cross GB, Lekurwale G, Choi H, Au V, Connolly J, Hibberd M, Green JA; Pascolizumab Tuberculosis Trial Team. Paton NI, et al. Among authors: lum l. J Infect Dis. 2024 Sep 23;230(3):590-597. doi: 10.1093/infdis/jiae104. J Infect Dis. 2024. PMID: 38527849 Clinical Trial.
Impact of CRISPR in cancer drug discovery.
Moffat J, Komor AC, Lum L. Moffat J, et al. Among authors: lum l. Science. 2024 Oct 25;386(6720):378-379. doi: 10.1126/science.adi6884. Epub 2024 Oct 24. Science. 2024. PMID: 39446947
A novel smartphone application to prevent postpartum depression adapted from an evidence-based cognitive behavioral therapy program: Individual end-user interviews to optimize the intervention.
Lewkowitz A, Guillen M, Ursinobared K, Baker R, Lum L, Battle C, Ware C, Ayala N, Clark M, Ranney M, Miller E, Guthrie K. Lewkowitz A, et al. Among authors: lum l. JMIR Hum Factors. 2024 Oct 14. doi: 10.2196/63143. Online ahead of print. JMIR Hum Factors. 2024. PMID: 39401408 Free article.
Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T.
Brown MC, D'Anniballe VM, Boczkowski D, Kandadi H, Sheikh N, Kornahrens W Jr, Heath EI, Thakur A, Chen W, Lum L, Cackowski FC, Boerner J, Gunn MD, Armstrong AJ, Nair SK. Brown MC, et al. Among authors: lum l. Cancer Res Commun. 2024 Oct 1;4(10):2724-2733. doi: 10.1158/2767-9764.CRC-24-0439. Cancer Res Commun. 2024. PMID: 39320053 Free PMC article.
481 results